| 일자 | 시간 | 출처 | 헤드라인 | 심볼 | 기업 |
| 2017/11/18 | 06:07 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(b) (15-12b) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 2017/11/14 | 20:01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 2017/11/10 | 07:02 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 2017/11/08 | 07:13 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 2017/11/08 | 07:13 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 2017/11/08 | 07:12 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 2017/11/08 | 07:11 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 2017/11/08 | 07:09 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 2017/11/08 | 07:09 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 2017/11/08 | 07:08 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 2017/11/08 | 07:07 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 2017/11/08 | 07:07 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 2017/11/08 | 07:06 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 2017/11/08 | 01:01 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 2017/11/08 | 00:24 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 2017/11/07 | 23:23 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 2017/11/07 | 23:22 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 2017/11/07 | 23:18 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 2017/11/07 | 23:17 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 2017/11/07 | 23:15 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 2017/11/07 | 22:57 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 2017/11/07 | 22:43 | GlobeNewswire Inc. | Ultragenyx Completes Tender Offer and Acquisition of Dimension Therapeutics | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 2017/11/07 | 06:08 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 2017/10/28 | 06:04 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 2017/10/26 | 21:55 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 2017/10/26 | 21:48 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 2017/10/26 | 21:30 | GlobeNewswire Inc. | Ultragenyx and Dimension Announce Expiration of Hart-Scott-Rodino Waiting Period for Ultragenyx’s Acquisition of Dimension | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 2017/10/24 | 00:15 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 2017/10/24 | 00:11 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 2017/10/17 | 23:38 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
